Assessing patient and provider satisfaction with tele-consults and in-hospital visits for cystic fibrosis care
FollowMuco : Study of Satisfaction of Patients and Care Providers for an Alternate Follow-up With In-hospital Consults and Tele-consult for Patients With Cystic Fibrosis
This study is testing how satisfied patients with cystic fibrosis and their doctors are with a new care approach that mixes online visits and in-person appointments.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 1 site (Pierre-Bénite) |
| Trial ID | NCT05249322 on ClinicalTrials.gov |
What this trial studies
This study evaluates the satisfaction levels of patients with cystic fibrosis and their care providers regarding a new follow-up approach that alternates between tele-consults and in-hospital consultations. Patients treated with Kaftrio® for at least one year and who are stable will participate in this one-year assessment. The study aims to determine the effectiveness and acceptance of this hybrid model of care, which was developed in response to the challenges posed by the pandemic.
Who should consider this trial
Good fit: Ideal candidates are patients with cystic fibrosis who have been stable on Kaftrio® for at least one year and meet specific eligibility criteria.
Not a fit: Patients who are pregnant, have undergone transplantation, or require specialized in-hospital follow-up may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance patient satisfaction and improve the management of cystic fibrosis through more flexible care options.
How similar studies have performed: While the approach of combining telemedicine with in-person visits is gaining traction, this specific study's methodology is relatively novel and has not been extensively tested in the context of cystic fibrosis.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients with cystic fibrosis * Patients treated with Kaftrio® since one year * autonomous patients * patients without cognitive disorders * Patients voluntary for this follow up * patients with two tele-communication tools * patients with FEV1\>50% * patients with less of 2 antibiotics cure per year Exclusion Criteria: * all transplanted patients * Pregnant patients * Particular follow up needed in-hospital consult * Persons deprived of their liberty by a judicial or administrative decision * Persons subject to psychiatric care * Persons admitted to a health or social establishment for purposes other than research * Persons not affiliated to a social security scheme or beneficiaries of a similar scheme
Where this trial is running
Pierre-Bénite
- Centre Hospitalier Lyon Sud — Pierre-Bénite, France (Recruiting)
Study contacts
- Principal investigator: Thomas VIDAL — adult cystic fibrosis centre Lyon
- Study coordinator: Thomas VIDAL
- Email: Thomas.vidal@chu-lyon.fr
- Phone: 478865671
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.